Sign in
Taking people in United StatesNo phase

Tests a pre-transplant exercise and diet program in older adults with myeloma

Tests exercise and diet before stem cell transplant in adults 60 or older with myeloma.

Key facts

Who runs it
Noha Mohamed Sharafeldin
Where
Birmingham, United StatesSee the site
Trial code
Registry title
Prehabilitation Feasibility Among Older Adults Undergoing Transplantation
Status
Recruiting
People taking part
30 people, planned
Started
10 Jul 2023
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • Multi-modal Exercise Regimen
  • Dietary Guidelines
Record updated
24 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 60 or older with multiple myeloma who are scheduled for an autologous stem cell transplant at UAB. It tests a program to prepare the body before the transplant.

Age
60 years or older
Sex
All sexes can join
Disease stage
Multiple myeloma, scheduled for an autologous stem cell transplant (ASCT) at UAB within 10 weeks of joining

Main reasons for not taking part

  • High risk of an impending pathologic fracture (bone break), judged with the Mirels score

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Diagnosis of Multiple Myeloma
  • Scheduled for ASCT at UAB within 10 weeks of study enrollment
  • age at ASCT ≥60y

Who cannot take part

  • at high risk for impending pathologic fracture using Mirels score

Where in United States

  • Kirklin Clinic of UAB HospitalBirmingham, United StatesContact: Landon Martin, BSTaking people

About the trial

What the trial wants to find out

This is a pilot feasibility trial among older adults (≥60y) scheduled to undergo Autologous Stem Cell transplantation at UAB. Participants will be randomized into either a prehabilitation program or an attention control group before their transplant. The primary outcomes will be feasibility and secondary outcomes include changes in physical function at the time of transplant and at 12 weeks follow up.

The 2 groups in the trial

  • TeleprehabTreatment being tested

    The participants selected for the teleprehab arm will undergo a supervised 8-week multi-modal exercise program in a telehealth format (using doxy.me, a free telehealth platform) delivered by licensed physical or occupational therapists who have undergone cancer specific rehabilitation training within Select Medical's ReVital® cancer rehabilitation program. Participants will attend teleprehab sessions 2 times per week for a total of 16 sessions.

    Treatment: Multi-modal Exercise Regimen and Dietary Guidelines

  • Attention ControlOther group

    The participants randomized to the attention control arm will not undergo an exercise regimen, but will be contacted by the study staff on the phone once a week..

    Treatment: Dietary Guidelines

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant
Plain-language title
Tests a pre-transplant exercise and diet program in older adults with myelomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
24 December 2025